These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 33148289)

  • 1. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on the in-hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population-based study.
    Wolfkamp W; Meijer J; van Hoeve JC; van Erning F; de Geus-Oei LF; de Hingh I; Veltman J; Siesling S;
    Cancer Med; 2024 Jan; 13(1):e6861. PubMed ID: 38197670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands.
    Toes-Zoutendijk E; Vink G; Nagtegaal ID; Spaander MCW; Dekker E; van Leerdam ME; Siesling S; Lansdorp-Vogelaar I; Elferink MAG;
    Eur J Cancer; 2022 Jan; 161():38-43. PubMed ID: 34915408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy).
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
    Eijkelboom AH; de Munck L; Lobbes MBI; van Gils CH; Wesseling J; Westenend PJ; Guerrero Paez C; Pijnappel RM; Verkooijen HM; Broeders MJM; Siesling S;
    Prev Med; 2021 Oct; 151():106602. PubMed ID: 34217417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
    Eijkelboom AH; de Munck L; Vrancken Peeters MTFD; Broeders MJM; Strobbe LJA; Bos MEMM; Schmidt MK; Guerrero Paez C; Smidt ML; Bessems M; Verloop J; Linn S; Lobbes MBI; Honkoop AH; van den Bongard DHJG; Westenend PJ; Wesseling J; Menke-van der Houven van Oordt CW; Tjan-Heijnen VCG; Siesling S;
    J Hematol Oncol; 2021 Apr; 14(1):64. PubMed ID: 33865430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study.
    Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S;
    Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study.
    Filipe MD; van Deukeren D; Kip M; Doeksen A; Pronk A; Verheijen PM; Heikens JT; Witkamp AJ; Richir MC
    Clin Breast Cancer; 2020 Dec; 20(6):454-461. PubMed ID: 32888855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
    Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
    Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
    Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
    Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.
    Nickson C; Smith MA; Feletto E; Velentzis LS; Broun K; Deij S; Grogan P; Hall M; He E; St John DJ; Lew JB; Procopio P; Simms KT; Worthington J; Mann GB; Canfell K
    Elife; 2023 Apr; 12():. PubMed ID: 37022767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic.
    Zhou JZ; Kane S; Ramsey C; Akhondzadeh M; Banerjee A; Shatsky R; Gold KA
    JAMA Netw Open; 2022 Feb; 5(2):e2148581. PubMed ID: 35166787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses.
    Battisti F; Falini P; Gorini G; Sassoli de Bianchi P; Armaroli P; Giubilato P; Giorgi Rossi P; Zorzi M; Battagello J; Senore C; Zappa M; Mantellini P
    Ann Ist Super Sanita; 2022; 58(1):16-24. PubMed ID: 35324470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cancer screening restart strategies after COVID-19 disruption.
    Kregting LM; Kaljouw S; de Jonge L; Jansen EEL; Peterse EFP; Heijnsdijk EAM; van Ravesteyn NT; Lansdorp-Vogelaar I; de Kok IMCM
    Br J Cancer; 2021 Apr; 124(9):1516-1523. PubMed ID: 33723386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Decker KM; Musto G; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Feely A; Galloway K; Lambert P
    Technol Cancer Res Treat; 2024; 23():15330338241263616. PubMed ID: 39053019
    [No Abstract]   [Full Text] [Related]  

  • 20. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
    Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
    JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.